Johnson & Johnson (JNJ) Total Liabilities (2009 - 2026)
Johnson & Johnson recorded quarterly Total Liabilities of $119.7 billion in Q1 2026, up 1.74% quarter-over-quarter from $117.7 billion in Q4 2025, and up 3.59% year-over-year from $115.6 billion in Q1 2025.
Johnson & Johnson's Total Liabilities history runs 18 years deep, the most recent figure standing at $119.7 billion for Q1 2026.
- In Q1 2026, Total Liabilities rose 3.59% year-over-year to $119.7 billion; the TTM figure through Mar 2026 stood at $119.7 billion (up 3.59% YoY), while the FY2025 annual figure was $117.7 billion, up 8.33% from the prior year.
- Total Liabilities came in at $119.7 billion for Q1 2026 at Johnson & Johnson, up from $117.7 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $125.1 billion in Q2 2023 to a low of $94.8 billion in Q4 2023.
- A 5-year average of $109.3 billion and a median of $109.1 billion in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities rose 20.7% in 2023 and slipped 18.51% in 2024, its largest moves.
- Johnson & Johnson's Total Liabilities stood at $100.5 billion in 2022, then declined by 1.73% to $98.8 billion in 2023, then increased by 9.95% to $108.6 billion in 2024, then increased by 8.33% to $117.7 billion in 2025, then gained by 1.74% to $119.7 billion in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $119.7 billion, $117.7 billion, and $113.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 85.38 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 119.71 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 143.08 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 82.75 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 83.31 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 32.76 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 117.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 66.37 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 60.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 119.71 Bn |
| Dec 28, 2025 | 117.67 Bn |
| Sep 28, 2025 | 113.54 Bn |
| Jun 29, 2025 | 114.92 Bn |
| Mar 30, 2025 | 115.56 Bn |
| Dec 29, 2024 | 108.61 Bn |
| Sep 29, 2024 | 108.13 Bn |
| Jun 30, 2024 | 109.55 Bn |
| Mar 31, 2024 | 101.95 Bn |
| Dec 31, 2023 | 98.78 Bn |
| Oct 1, 2023 | 94.83 Bn |
| Jul 2, 2023 | 115.28 Bn |
| Apr 2, 2023 | 125.10 Bn |
| Jan 1, 2023 | 110.57 Bn |
| Oct 2, 2022 | 100.53 Bn |
| Jul 3, 2022 | 101.37 Bn |
| Apr 3, 2022 | 103.65 Bn |
| Jan 2, 2022 | 108.00 Bn |
| Oct 3, 2021 | 108.96 Bn |
| Jul 4, 2021 | 106.86 Bn |
| Apr 4, 2021 | 106.72 Bn |
| Jan 3, 2021 | 111.62 Bn |
| Sep 27, 2020 | 106.22 Bn |
| Jun 28, 2020 | 95.40 Bn |
| Mar 29, 2020 | 93.72 Bn |
| Dec 29, 2019 | 98.26 Bn |
| Sep 29, 2019 | 97.31 Bn |
| Jun 30, 2019 | 94.33 Bn |
| Mar 31, 2019 | 91.07 Bn |
| Dec 30, 2018 | 93.20 Bn |
| Sep 30, 2018 | 91.08 Bn |
| Jul 1, 2018 | 92.48 Bn |
| Apr 1, 2018 | 93.37 Bn |
| Dec 31, 2017 | 97.14 Bn |
| Oct 1, 2017 | 81.68 Bn |
| Jul 2, 2017 | 80.89 Bn |
| Apr 2, 2017 | 74.58 Bn |
| Jan 1, 2017 | 70.79 Bn |
| Oct 2, 2016 | 67.60 Bn |
| Jul 3, 2016 | 67.34 Bn |
| Apr 3, 2016 | 63.58 Bn |
| Jan 3, 2016 | 62.26 Bn |
| Sep 27, 2015 | 61.71 Bn |
| Jun 28, 2015 | 60.91 Bn |
| Mar 29, 2015 | 60.71 Bn |
| Dec 28, 2014 | 60.61 Bn |
| Sep 28, 2014 | 55.51 Bn |
| Jun 29, 2014 | 57.15 Bn |
| Mar 30, 2014 | 56.75 Bn |
| Dec 29, 2013 | 58.63 Bn |
| Sep 29, 2013 | 57.13 Bn |
| Jun 30, 2013 | 54.66 Bn |
| Mar 31, 2013 | 54.68 Bn |
| Dec 30, 2012 | 56.52 Bn |
| Sep 30, 2012 | 55.19 Bn |
| Jul 1, 2012 | 55.32 Bn |
| Apr 1, 2012 | 54.83 Bn |
| Jan 1, 2012 | 56.56 Bn |
| Oct 2, 2011 | 50.29 Bn |
| Jul 3, 2011 | 49.98 Bn |
| Apr 3, 2011 | 48.29 Bn |
| Jan 2, 2011 | 46.33 Bn |
| Oct 3, 2010 | 40.96 Bn |
| Jul 4, 2010 | 39.45 Bn |
| Apr 4, 2010 | 40.53 Bn |
| Jan 3, 2010 | 44.09 Bn |
| Sep 27, 2009 | 41.17 Bn |
| Jun 28, 2009 | 41.19 Bn |